Injection site reactions include pain, redness, itching or raised rubbery lumps
It is considered one of the main risk factors for the development of T2D, a metabolic disease characterized by insulin resistance and/or impaired secretion of this hormone, which leads to high blood glucose levels (Wysocki et al, 2024)
The medical community has a name for it: Telogen Effluvium
Unlike gradual vision loss where patients can adapt over time, NAIONs acute onset leaves victims unprepared for a world designed for sighted individuals, necessitating immediate accommodations, vocational rehabilitation, and extensive support services
Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: potential repurposing of anti-cancer drug as a disease-modifying agent in parkinsons disease